Skip to content

Emails Promoting COVID-19 Vaccination Among Healthcare Workers

Evaluation of an Email Intervention Promoting COVID-19 Vaccination Among Healthcare Workers

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04728594
Enrollment
9566
Registered
2021-01-28
Start date
2021-01-15
Completion date
2021-01-20
Last updated
2021-07-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Communication, Vaccination Refusal

Keywords

Immunization, Persuasive Communication, Electronic Mail, Economics, Behavioral, Psychology

Brief summary

In this evaluation, two versions of emails will be sent to Geisinger employees who have not been vaccinated against COVID-19. A delayed-contact control group will be emailed after a delay of at least two days. The researchers hypothesize that either of the emails - which use content informed by behavioral nudge theory - will lead to more COVID-19 vaccinations than the delayed-contact control group.

Detailed description

The researchers aim to evaluate the effectiveness of email reminders in promoting COVID-19 vaccinations among Geisinger employees. The project will compare two emails, which will vary in the subject line and email content. Both emails will test different approaches that draw from principles in behavioral science: social proof, reframing, and scarcity. Employees receiving these emails will be compared with employees in a delayed-contact group, who will not receive emails. Employees in the control group will later receive one of the emails.The responses to the emails will help determine the communications later sent to the control group. All emails will ask recipients if they want to receive a COVID-19 vaccination. If they click on a hyperlink indicating yes, they will be forwarded to an online registration and scheduling homepage. If they click on a hyperlink indicating no, they will be forwarded to an online questionnaire surveying people about their main reason for declining the vaccine at this time. The questionnaire will automatically present information intended to assuage the specific concern that people endorse, followed by a hyperlink to the scheduling site. The data will be analyzed with logistic regression models with the control group as the reference group, to compare the two email conditions versus the control group. This set of analyses will only be conducted for scheduling a vaccination appointment as opposed to email engagement outcomes (e.g., number of emails opened), which will not be applicable for the control group. A second set of logistic regression models predicting scheduling a vaccination appointment and email engagement will also be run, comparing the two email conditions against each other. The data will be examined two days later (to help decide which email to send to the delayed-control group) and four days later (when the policy for employee vaccination will change, making the content of the email irrelevant). Update: The researchers looked at 3 days of data - as the emails to the delayed contact group were only sent at that time - and 4 days of data when the policy for employee vaccinations changed.

Interventions

BEHAVIORALSocial Proof

Email

BEHAVIORALReframing

Email

BEHAVIORALScarcity Message

Email

Sponsors

Geisinger Clinic
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Caregiver)

Masking description

Participants will not know what group they are in. The relevant care provider (either their primary care provider or provider administering the vaccine) will not know about this study or assignment into groups.

Intervention model description

1 x 3 design

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Employees at Geisinger Health System who have not gotten a COVID-19 vaccination

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frameDescription
Number of Employees Who Scheduled Vaccination Appointments After 3 Days3 daysBinary variable of a scheduled vaccination appointment 3 days after the emails were sent

Secondary

MeasureTime frameDescription
Number of Employees Who Opened Emails After 3 Days3 daysBinary variable indicating whether the employee opened the email 3 days after the emails were sent
Number of Employees Who Clicked Scheduling Links After 3 Days3 daysBinary variable indicating whether the employee clicked the link to schedule a vaccination appointment 3 days after the emails were sent

Other

MeasureTime frameDescription
Number of Employees Who Scheduled Vaccination Appointments Until Policy Change (4 Days)4 daysBinary variable of a scheduled vaccination appointment up to the end of January 19, when new distribution policies were enacted.
Number of Employees Who Opened Emails Until Policy Change (4 Days)4 daysBinary variable indicating whether the employee opened the email up to the end of January 19, when new distribution policies were enacted.
Number of Employees Who Clicked the Scheduling Link Until Policy Change (4 Days)4 daysBinary variable indicating whether the employee clicked the link to schedule a vaccination appointment up to the end of January 19, when new distribution policies were enacted.

Countries

United States

Participant flow

Participants by arm

ArmCount
Delayed Contact
This group will not receive an email for at least two days.
3,178
Social Proof
This group will receive an email that points out that vaccine availability for employees will soon be limited. It also emphasizes how many fellow health care workers have been vaccinated. Seeing the behaviors of other people might encourage recipients to copy that behavior. Social Proof: Email Scarcity Message: Email
3,198
Reframing Side Effects and Adverse Reactions
This group will receive an email that points out that vaccine availability for employees will soon be limited. It also addresses concerns about the side effects and adverse reactions of the vaccine. Due to potentially overblown concerns about the vaccine caused by the salience of side effects in the (social) media, the email attempts to reframe the risks by explicitly noting the small possibility of being affected by serious side effects and by contrasting that to the more severe effects of COVID-19. As a result of this reframing, recipients might recalibrate their perception of risks and benefits and opt for vaccination. Reframing: Email Scarcity Message: Email
3,190
Total9,566

Baseline characteristics

CharacteristicTotalDelayed ContactSocial ProofReframing Side Effects and Adverse Reactions
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
0 Participants
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
United States
9566 participants3178 participants3198 participants3190 participants
Sex: Female, Male
Female
0 Participants
Sex: Female, Male
Male
0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
0 / 00 / 00 / 0
other
Total, other adverse events
0 / 00 / 00 / 0
serious
Total, serious adverse events
0 / 00 / 00 / 0

Outcome results

Primary

Number of Employees Who Scheduled Vaccination Appointments After 3 Days

Binary variable of a scheduled vaccination appointment 3 days after the emails were sent

Time frame: 3 days

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Delayed ContactNumber of Employees Who Scheduled Vaccination Appointments After 3 Days101 Participants
Social ProofNumber of Employees Who Scheduled Vaccination Appointments After 3 Days207 Participants
Reframing Side Effects and Adverse ReactionsNumber of Employees Who Scheduled Vaccination Appointments After 3 Days220 Participants
Comparison: We conducted a logistic regression with the two experimental conditions as dummy variables with delayed contact as the reference group.p-value: <0.00195% CI: [1.65, 2.69]Regression, Logistic
Comparison: We conducted a logistic regression with the two experimental conditions as dummy variables with delayed contact as the reference group.p-value: <0.00195% CI: [1.77, 2.87]Regression, Logistic
Comparison: We conducted a logistic regression with the two experimental conditions as dummy variables with delayed contact as the reference group.p-value: <0.00195% CI: [0.88, 1.3]Regression, Logistic
Secondary

Number of Employees Who Clicked Scheduling Links After 3 Days

Binary variable indicating whether the employee clicked the link to schedule a vaccination appointment 3 days after the emails were sent

Time frame: 3 days

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Delayed ContactNumber of Employees Who Clicked Scheduling Links After 3 Days562 Participants
Social ProofNumber of Employees Who Clicked Scheduling Links After 3 Days382 Participants
Secondary

Number of Employees Who Opened Emails After 3 Days

Binary variable indicating whether the employee opened the email 3 days after the emails were sent

Time frame: 3 days

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Delayed ContactNumber of Employees Who Opened Emails After 3 Days1481 Participants
Social ProofNumber of Employees Who Opened Emails After 3 Days1398 Participants
Other Pre-specified

Number of Employees Who Clicked the Scheduling Link Until Policy Change (4 Days)

Binary variable indicating whether the employee clicked the link to schedule a vaccination appointment up to the end of January 19, when new distribution policies were enacted.

Time frame: 4 days

Other Pre-specified

Number of Employees Who Opened Emails Until Policy Change (4 Days)

Binary variable indicating whether the employee opened the email up to the end of January 19, when new distribution policies were enacted.

Time frame: 4 days

Other Pre-specified

Number of Employees Who Scheduled Vaccination Appointments Until Policy Change (4 Days)

Binary variable of a scheduled vaccination appointment up to the end of January 19, when new distribution policies were enacted.

Time frame: 4 days

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026